Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $336.1700 (-0.83%) ($336.1700 - $336.1700) on Thu. Jan. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.81% (three month average) | RSI | 22 | Latest Price | $336.1700(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | Weekly Trend | REGN declines -6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.905% in a week (0% probabilities). VIXM(-24%) VXX(-10%) IGOV(-6%) TLT(-5%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.905% (StdDev 1.81%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $366.56 | 5 Day Moving Average | $340.78(-1.35%) | 10 Day Moving Average | $354.44(-5.15%) | 20 Day Moving Average | $366.56(-8.29%) | To recent high | -14% | To recent low | 9.7% | Market Cap | $35.644b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |